The Rate and Risk Factors of Deep Brain Stimulation-Associated Complications: A Single-Center Experience.
Journal
Operative neurosurgery (Hagerstown, Md.)
ISSN: 2332-4260
Titre abrégé: Oper Neurosurg (Hagerstown)
Pays: United States
ID NLM: 101635417
Informations de publication
Date de publication:
26 Aug 2024
26 Aug 2024
Historique:
received:
24
04
2024
accepted:
10
07
2024
medline:
26
8
2024
pubmed:
26
8
2024
entrez:
26
8
2024
Statut:
aheadofprint
Résumé
Deep brain stimulation (DBS) is an established neurosurgical treatment of a variety of neurological disorders. DBS is considered a safe and effective neurosurgical procedure; however, surgical complications are inevitable, and clinical outcomes may vary. The aim of this study was to describe DBS complications at a large clinical center in the United States and to investigate the relationship between patients' baseline characteristics, surgical technique, and operative complications. We identified all patients who underwent DBS lead implantation at our center between 1st January 2012 and 1st January 2020. We extracted relevant information regarding patient demographics, surgical details, clinical complications, and clinical outcomes from the electronic medical records. A total of 859 leads were implanted in 481 patients (153 men, 328 women). The mean patient age at the time of the surgery was 65 years, with the mean disease duration of 13.3 years. There were no mortalities and 57 readmissions within 30 days (mean = 14.2 days). The most common complications included pneumocephalus (n = 661), edema (n = 78), altered mental state (n = 35), implantable pulse generator discomfort (n = 34), hemorrhage (n = 26), and infection (n = 23). Most notably, the use of general anesthesia, hypertension, heart disease, and depression were associated with significantly longer postoperative stay. High preoperative body mass index was associated with higher rates of surgery-related infections and lead revision/explantation. The intraoperative mean arterial pressure, anesthesia type, and frame apparatus were all important predictors of postoperative pneumocephalus. In this report, we described the rates and types of complications associated with DBS surgery at a large neurosurgical center in the United States. The novel insights highlighted in this study present an opportunity to further improve the clinical outcomes and patient selection in DBS surgery.
Sections du résumé
BACKGROUND AND OBJECTIVES
OBJECTIVE
Deep brain stimulation (DBS) is an established neurosurgical treatment of a variety of neurological disorders. DBS is considered a safe and effective neurosurgical procedure; however, surgical complications are inevitable, and clinical outcomes may vary. The aim of this study was to describe DBS complications at a large clinical center in the United States and to investigate the relationship between patients' baseline characteristics, surgical technique, and operative complications.
METHODS
METHODS
We identified all patients who underwent DBS lead implantation at our center between 1st January 2012 and 1st January 2020. We extracted relevant information regarding patient demographics, surgical details, clinical complications, and clinical outcomes from the electronic medical records.
RESULTS
RESULTS
A total of 859 leads were implanted in 481 patients (153 men, 328 women). The mean patient age at the time of the surgery was 65 years, with the mean disease duration of 13.3 years. There were no mortalities and 57 readmissions within 30 days (mean = 14.2 days). The most common complications included pneumocephalus (n = 661), edema (n = 78), altered mental state (n = 35), implantable pulse generator discomfort (n = 34), hemorrhage (n = 26), and infection (n = 23). Most notably, the use of general anesthesia, hypertension, heart disease, and depression were associated with significantly longer postoperative stay. High preoperative body mass index was associated with higher rates of surgery-related infections and lead revision/explantation. The intraoperative mean arterial pressure, anesthesia type, and frame apparatus were all important predictors of postoperative pneumocephalus.
CONCLUSION
CONCLUSIONS
In this report, we described the rates and types of complications associated with DBS surgery at a large neurosurgical center in the United States. The novel insights highlighted in this study present an opportunity to further improve the clinical outcomes and patient selection in DBS surgery.
Identifiants
pubmed: 39185858
doi: 10.1227/ons.0000000000001323
pii: 01787389-990000000-01297
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
Copyright © Congress of Neurological Surgeons 2024. All rights reserved.
Références
Herrington TM, Cheng JJ, Eskandar EN. Mechanisms of deep brain stimulation [published correction appears in J Neurophysiol. 2020 Mar 1;123(3):1277]. J Neurophysiol. 2016;115(1):19-38.
Jakobs M, Fomenko A, Lozano AM, Kiening KL. Cellular, molecular, and clinical mechanisms of action of deep brain stimulation—a systematic review on established indications and outlook on future developments. EMBO Mol Med. 2019;11(4):e9575.
Chiken S, Nambu A. Mechanism of deep brain stimulation: inhibition, excitation, or disruption? Neuroscientist. 2016;22(3):313-322.
Products and Medical Procedures. U.S. Food & Drug Administration. 2023. Accessed February 11, 2024. https://www.fda.gov/medical-devices/products-and-medical-procedures
FitzGerald J. Neuromodulation: Deep Brain Stimulation Targets. International Neuromodulation Society. 2018. https://www.neuromodulation.com/fact_sheet_brain_targets. Accessed February 11, 2024.
Parittotokkaporn S, Varghese C, O'Grady G, Svirskis D, Subramanian S, O'Carroll SJ. Non-invasive neuromodulation for bowel, bladder and sexual restoration following spinal cord injury: a systematic review. Clin Neurol Neurosurg. 2020;194:105822.
Holtzheimer PE, Mayberg HS. Neuromodulation for treatment-resistant depression [published correction appears in F1000 Med Rep. 2014;4:22]. F1000 Med Rep. 2012;4:22.
Xu W, Zhang C, Deeb W, et al. Deep brain stimulation for Tourette's syndrome. Transl Neurodegener. 2020;9:4.
Wathen CA, Frizon LA, Maiti TK, Baker KB, Machado AG. Deep brain stimulation of the cerebellum for poststroke motor rehabilitation: from laboratory to clinical trial. Neurosurg Focus. 2018;45(2):e13.
Tiefenbach J, Chan HH, Machado AG, Baker KB. Neurostimulation for functional recovery after traumatic brain injury: current evidence and future directions for invasive surgical approaches. Neurosurgery. 2022;91(6):823-830.
Piltsis JG, Khazen O, Patel S. Deep Brain Stimulation. American Association of Neurological Surgeon; 2023. https://www.aans.org/en/Patients/Neurosurgical-Conditions-and-Treatments/Deep-Brain-Stimulation. Accessed February 17, 2024.
Hariz MI. Complications of deep brain stimulation surgery. Mov Disord. 2002;17(Suppl 3):S162-S166.
Engel K, Huckhagel T, Gulberti A, et al. Towards unambiguous reporting of complications related to deep brain stimulation surgery: a retrospective single-center analysis and systematic review of the literature. PLoS One. 2018;13(8):e0198529.
Koh EJ, Golubovsky JL, Rammo R, et al. Estimating the risk of deep brain stimulation in the modern era: 2008 to 2020. Oper Neurosurg. 2021;21(5):277-290.
Vandenbroucke JP, von Elm E, Altman DG, et al. Strengthening the reporting of observational studies in epidemiology (STROBE): explanation and elaboration. Plos Med. 2007;4(10):e297.
Koy A, Bockhorn N, Kühn AA, et al. Adverse events associated with deep brain stimulation in patients with childhood-onset dystonia. Brain Stimul. 2019;12(5):1111-1120.
Davidson B, Elkaim LM, Lipsman N, Ibrahim GM. Editorial. An ethical framework for deep brain stimulation in children. Neurosurg Focus. 2018;45(3):e11.
Rothman KJ. No adjustments are needed for multiple comparisons. Epidemiology. 1990;1(1):43-46.
Feise RJ. Do multiple outcome measures require p-value adjustment? BMC Med Res Methodol. 2002;2:8.
Kantzanou M, Korfias S, Panourias I, Sakas DE, Karalexi MA. Deep brain stimulation-related surgical site infections: a systematic review and meta-analysis. Neuromodulation. 2021;24(2):197-211.
Atchley TJ, Elsayed GA, Sowers B, et al. Incidence and risk factors for seizures associated with deep brain stimulation surgery. J Neurosurg. 2020;135(1):279-283.
Lu W, Chang X, Bo L, et al. Risk factors for delirium after deep brain stimulation surgery under total intravenous anesthesia in Parkinson's disease patients. Brain Sci. 2022;13(1):25.
Tiefenbach J, Favi Bocca L, Hogue O, Nero N, Baker KB, Machado AG. Intracranial bleeding in deep brain stimulation surgery: a systematic review and meta-analysis. Stereotact Funct Neurosurg. 2023;101(3):207-216.
Deng H, Yue JK, Wang DD. Trends in safety and cost of deep brain stimulation for treatment of movement disorders in the United States: 2002-2014. Br J Neurosurg. 2021;35(1):57-64.
Liu Z, He S, Li L. General anesthesia versus local anesthesia for deep brain stimulation in Parkinson's disease: a meta-analysis. Stereotact Funct Neurosurg. 2019;97(5-6):381-390.
Ramayya AG, Abdullah KG, Mallela AN, et al. Thirty-day readmission rates following deep brain stimulation surgery. Neurosurgery. 2017;81(2):259-267.
Falowski SM, Bakay RA. Revision surgery of deep brain stimulation leads. Neuromodulation. 2016;19(5):443-450.
Feldmann LK, Neumann WJ, Faust K, Schneider GH, Kühn AA. Risk of infection after deep brain stimulation surgery with externalization and local-field potential recordings: twelve-year experience from a single institution. Stereotact Funct Neurosurg. 2021;99(6):512-520.
Kaspersen KA, Pedersen OB, Petersen MS, et al. Obesity and risk of infection: results from the Danish blood donor study. Epidemiology. 2015;26(4):580-589.
Binder DK, Rau GM, Starr PA. Risk factors for hemorrhage during microelectrode-guided deep brain stimulator implantation for movement disorders. Neurosurgery. 2005;56(4):722-732.
Wu B, Xu J, Zhang C, et al. The effect of surgical positioning on pneumocephalus in subthalamic nucleus deep brain stimulation surgery for Parkinson disease. Neuromodulation. 2023;26(8):1714-1723.
O'Sullivan R, Inouye SK, Meagher D. Delirium and depression: inter-relationship and clinical overlap in elderly people. Lancet Psychiatry. 2014;1(4):303-311.
Yamato K, Ikeda A, Endo M, et al. An association between cancer type and delirium incidence in Japanese elderly patients: a retrospective longitudinal study. Cancer Med. 2023;12(3):2407-2416.